Guangzhou Medical University & AstraZeneca: advancing understanding of COPD in China

We’re working with Guangzhou Medical University, one of the world’s leading centres for research into respiratory disease, to advance the scientific understanding of Chronic Obstructive Pulmonary Disease (COPD). Our team had previously carried out COPD studies in many western countries and was interested in comparing findings with those from China, where COPD prevalence is high and rising rapidly. Our aim is to find better ways of diagnosing and preventing incidence.

Related articles